Bottom line
BBIN vs MRSAX: the short answer
BBIN (JPMorgan BetaBuilders International Equity ETF) and MRSAX (MFS Research International Fund) are quite different portfolios: only about 34% of their top holdings (by weight) are shared.
But BBIN is far broader, holding 643 positions to 121 for MRSAX, so beyond the top names it adds exposure MRSAX doesn't have.
BBIN is cheaper at 0.07% vs 0.99% — a difference of $92 a year per $10,000 invested.
Over five years, BBIN returned +9.1% a year vs +2.6% for MRSAX (reporting dates differ).
MRSAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
BBIN vs MRSAX side by side
| BBIN | MRSAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | MFS |
| Category | International Stock | International Stock |
| Expense ratio | 0.07% | 0.99% |
| Annual cost per $10k | $7 | $99 |
| 10-yr cost on $10k (prospectus) | $90 | $1,728 |
| Max front load | None | 5.75% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +32.1% | −3.1% |
| 5-yr return (annualized) | +9.1% | +2.6% |
| 10-yr return (annualized) | — | +4.5% |
| Best quarter | +18.3% | +16.5% |
| Worst quarter | −23.1% | −19.7% |
| Net assets (fund) | $6.6B | $17.8B |
| Number of holdings | 643 | 121 |
| Portfolio turnover | 5% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBIN | MRSAX | Difference |
|---|---|---|---|
| 2024 | +3.5% | +2.9% | +0.7% |
| 2023 | +18.2% | +13.1% | +5.1% |
| 2022 | −14.1% | −17.5% | +3.4% |
| 2021 | +11.4% | +11.6% | −0.2% |
| 2020 | +8.6% | +12.9% | −4.3% |
Source: Fund prospectus bar charts
Holdings overlap
10 of BBIN's top 25 holdings also appear in MRSAX's top 25.
| Holding | BBIN | MRSAX |
|---|---|---|
| ASML Holding NV | 2.93% | 2.21% |
| Roche Holding AG | 1.38% | 1.36% |
| Novartis AG | 1.37% | 2.12% |
| AstraZeneca plc | 1.21% | 1.78% |
| TotalEnergies SE | 0.85% | 2.10% |
| Schneider Electric SE | 0.83% | 2.82% |
| UBS Group AG | 0.72% | 1.36% |
| Banco Bilbao Vizcaya Argentaria SA | 0.72% | 1.38% |
| Hitachi Ltd. | 0.68% | 2.45% |
| Tokyo Electron Ltd. | 0.68% | 1.90% |
Source: SEC Form N-PORT
BBIN top 10
- ASML Holding NV — 2.93%
- HSBC Holdings plc — 1.68%
- Roche Holding AG — 1.38%
- Novartis AG — 1.37%
- AstraZeneca plc — 1.21%
- Shell plc — 1.17%
- Mitsubishi UFJ Financial Group, Inc. — 1.16%
- Nestle SA — 1.14%
- Siemens AG — 1.07%
- Toyota Motor Corp. — 0.99%
MRSAX top 10
- Mizuho Financial Group Inc — 2.90%
- Schneider Electric SE — 2.82%
- Hitachi Ltd — 2.45%
- ASML Holding NV — 2.21%
- Taiwan Semiconductor Manufacturing Co Ltd — 2.21%
- Novartis AG — 2.12%
- TotalEnergies SE — 2.10%
- Tokyo Electron Ltd — 1.90%
- AstraZeneca PLC — 1.78%
- Linde PLC — 1.76%
FAQ
What is the difference between BBIN and MRSAX?
Which is cheaper, BBIN or MRSAX?
Should I own both BBIN and MRSAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.